Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

10.68
-1.3800-11.44%
Post-market: 10.680.00000.00%18:43 EDT
Volume:2.57M
Turnover:27.99M
Market Cap:1.47B
PE:-2.07
High:11.96
Open:11.74
Low:10.66
Close:12.06
Loading ...

Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Feb

Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating

TIPRANKS
·
13 Feb

Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating

TIPRANKS
·
13 Feb

Stock Track | Arrowhead Pharmaceuticals Plummets 5.08% Intraday on Widening Q1 Losses and Missed Expectations

Stock Track
·
12 Feb

ARWR: Multiple Catalysts Ahead in 2025…

Zacks Small Cap Research
·
12 Feb

Arrowhead Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.
·
12 Feb

Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

TIPRANKS
·
12 Feb

Arrowhead Pharmaceuticals Price Target Maintained With a $42.00/Share by RBC Capital

Dow Jones
·
12 Feb

Stock Track | Arrowhead Pharmaceuticals Plunges Over 8% in Pre-market Trading as Disappointing Q1 Earnings Weigh on Stock

Stock Track
·
11 Feb

Stock Track | Arrowhead Pharmaceuticals Plunges 6.63% in Pre-market Trading as Earnings Disappoint Investors

Stock Track
·
11 Feb

Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating

TIPRANKS
·
11 Feb

Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ...

GuruFocus.com
·
11 Feb

Arrowhead Pharmaceuticals Reports Q1 2025 Financial Results

TIPRANKS
·
11 Feb

Arrowhead Pharmaceuticals: Strategic Licensing Deal and Upcoming Drug Launch Drive Buy Rating

TIPRANKS
·
11 Feb

Arrowhead Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Feb

Arrowhead Pharmaceuticals Fiscal Q1 Loss Widens, Revenue Declines -- Shares Down After Hours

MT Newswires Live
·
11 Feb

Arrowhead Pharma Q1 2025 GAAP EPS $(1.39) Misses $(0.63) Estimate, Sales $2.50M Miss $65.47M Estimate

Benzinga
·
11 Feb

Arrowhead Research: Fiscal Q1 Earnings Snapshot

Associated Press Finance
·
11 Feb

Arrowhead reports Q1 EPS ($1.39), consensus (72c)

TIPRANKS
·
11 Feb

Arrowhead Closes Licensing, Collaboration Agreement With Sarepta

MT Newswires Live
·
10 Feb